Cargando…
Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients
Autores principales: | Fava, M, Johe, K, Ereshefsky, L, Gertsik, L G, English, B A, Bilello, J A, Thurmond, L M, Johnstone, J, Dickerson, B C, Makris, N, Hoeppner, B B, Flynn, M, Mischoulon, D, Kinrys, G, Freeman, M P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030463/ https://www.ncbi.nlm.nih.gov/pubmed/27528461 http://dx.doi.org/10.1038/mp.2016.140 |
Ejemplares similares
-
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients
por: Fava, M, et al.
Publicado: (2016) -
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder
por: Papakostas, G. I., et al.
Publicado: (2019) -
NSI‐189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats
por: Tajiri, Naoki, et al.
Publicado: (2017) -
Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes
por: Jolivalt, C. G., et al.
Publicado: (2022) -
Behavioral and Histopathological Assessment of Adult Ischemic Rat Brains after Intracerebral Transplantation of NSI-566RSC Cell Lines
por: Tajiri, Naoki, et al.
Publicado: (2014)